Rising Regulation And Capital Strains Will Weaken EV Outlook

Published
08 May 25
Updated
16 Aug 25
AnalystLowTarget's Fair Value
US$6.00
20.8% overvalued intrinsic discount
16 Aug
US$7.25
Loading
1Y
-75.8%
7D
-4.0%

Author's Valuation

US$6.0

20.8% overvalued intrinsic discount

AnalystLowTarget Fair Value

Key Takeaways

  • Revenue growth and profitability are threatened by regulatory uncertainty, reduced demand in core markets, and rising compliance and input costs.
  • Sustained cash flow pressures and intensifying competition create risks of margin compression, asset dependency, and diminished market diversification.
  • Benefiting from energy transition trends, Aspen Aerogels is positioned for long-term profitability through cost discipline, innovation, major OEM partnerships, and strong project backlogs.

Catalysts

About Aspen Aerogels
    An aerogel technology company, designs, develops, manufactures, and sells aerogel materials primarily for use in the energy industrial, sustainable insulation materials, and electric vehicle (EV) markets in the United States, Canada, Asia, Europe, and Latin America.
What are the underlying business or industry changes driving this perspective?
  • Growing regulatory and political uncertainty around electrification policies, especially in the U.S., is leading major automotive OEMs to delay or reassess electric vehicle rollout plans, which could result in chronic stagnation or contraction in Aspen Aerogels' core EV Thermal Barrier segment, severely limiting future revenue growth and creating a persistent customer concentration risk.
  • Intensified global de-carbonization efforts and the shift to alternative energy sources may permanently reduce demand for traditional energy infrastructure insulation such as pipelines, refineries, and especially subsea applications. With Energy & Industrial segment revenues already experiencing significant declines, this foundational erosion is likely to drive recurring revenue weakness and structural gross margin deterioration.
  • Continued heavy capital requirements due to both R&D and plant investments, paired with deep and prolonged cyclicality in key end-markets, will exhaust most cash flow improvements derived from recent cost-cutting. This will constrain net margin expansion and leave the business dependent on asset sales and ongoing restructuring just to maintain liquidity.
  • The competitive threat of alternative insulation technologies and advanced battery thermal management solutions could accelerate, with commoditization or technological obsolescence eroding Aspen's pricing power and leading to ongoing ASP compression and substantial gross margin pressure in both existing and future end-markets.
  • Increased regulatory scrutiny and tightened global trade policies could raise input and compliance costs and restrict Aspen Aerogels' access to international markets, thereby constricting total addressable market growth, reducing revenue diversification, and amplifying sensitivity to domestic policy reversals and economic cycles.

Aspen Aerogels Earnings and Revenue Growth

Aspen Aerogels Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • This narrative explores a more pessimistic perspective on Aspen Aerogels compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
  • The bearish analysts are assuming Aspen Aerogels's revenue will decrease by 0.6% annually over the next 3 years.
  • The bearish analysts assume that profit margins will increase from -78.5% today to 11.6% in 3 years time.
  • The bearish analysts expect earnings to reach $47.0 million (and earnings per share of $0.54) by about August 2028, up from $-311.9 million today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 16.0x on those 2028 earnings, up from -1.9x today. This future PE is lower than the current PE for the US Chemicals industry at 25.1x.
  • Analysts expect the number of shares outstanding to grow by 6.85% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.84%, as per the Simply Wall St company report.

Aspen Aerogels Future Earnings Per Share Growth

Aspen Aerogels Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • The company is benefiting from strong secular trends in energy transition and electrification, with management expressing confidence that electrification through this decade will be a major driver for both their Thermal Barrier and Energy Industrial businesses, which could underpin durable revenue growth and profitability.
  • Aspen Aerogels has demonstrated significant cost discipline by removing approximately $65 million in fixed costs and optimizing its cost structure, putting it in a position to be profitable even at lower revenue levels and supporting improved net margins going forward.
  • There is ongoing and increasing engagement with major global OEMs in the electric vehicle market, such as General Motors, Stellantis, ACC, and Daimler, with expectations of new launches and volume ramps beginning in Q4 2025 and continuing into 2027, suggesting diversified and growing revenue streams that may accelerate earnings.
  • The Energy & Industrial segment, despite near-term weakness, is positioned to show renewed growth and high gross profit margins based on robust project backlogs in Subsea and LNG markets, with management expecting attractive project revenues in 2026 and beyond, supporting a recovery in segment revenue and profitability.
  • Continued product innovation and established proprietary technology-combined with the ability to flexibly supply both domestic and international markets and to respond to regulatory and customer shifts-provide Aspen Aerogels with a strong competitive moat, increasing the company's ability to maintain pricing power and achieve higher long-term returns on invested capital.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The assumed bearish price target for Aspen Aerogels is $6.0, which represents the lowest price target estimate amongst analysts. This valuation is based on what can be assumed as the expectations of Aspen Aerogels's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $14.0, and the most bearish reporting a price target of just $6.0.
  • In order for you to agree with the bearish analysts, you'd need to believe that by 2028, revenues will be $404.8 million, earnings will come to $47.0 million, and it would be trading on a PE ratio of 16.0x, assuming you use a discount rate of 7.8%.
  • Given the current share price of $7.25, the bearish analyst price target of $6.0 is 20.8% lower. Despite analysts expecting the underlying buisness to improve, they seem to believe the market's expectations are too high.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives